CXCL12 and cancer: The difference in cell growth induced by BoxA and CXCL12 is critical from a translational point of view: Even if both were equally potent in inducing Immunogenic Surrender, injecting CXCL12 would also promote cancer growth, while our data indicate that injecting BoxA does restrain it.